XML 32 R12.htm IDEA: XBRL DOCUMENT v3.20.4
Equity Method Investments
12 Months Ended
Dec. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments
For each of the following investments, we have the ability to exercise significant influence over these investments based on certain governance provisions and our participation in the significant activities and decisions that impact the management and economic performance of the investments.
Equity method investments comprise the following as of the dates indicated:  
December 31,
20202019
OwnershipAmountOwnershipAmount
Mattox (1)
79%$163 $— 
Amberjack – Series A / Series B
75.0% / 50.0%
382 
75.0% / 50.0%
426 
Mars71.5%152 71.5%161 
Bengal50.0%88 50.0%88 
Permian Basin50.0%83 50.0%91 
LOCAP41.48%12 41.48%
Explorer (2)
38.59%73 38.59%88 
Poseidon 36.0%— 36.0%— 
Colonial (2)
16.125%29 16.125%30 
Proteus10.0%14 10.0%15 
Endymion10.0%17 10.0%18 
$1,013 $926 
(1) Mattox was acquired as part of the April 2020 Transaction. This interest has been accounted for on a prospective basis. See below for additional information.
(2) As part of the June 2019 Acquisition, these interests have been accounted for prospectively. See below for additional information.

We acquired a 79% interest in Mattox from SGOM in the April 2020 Transaction. This investment qualifies for equity method accounting, as we exercise significant influence but do not control this investment. Upon acquisition, we recorded SGOM’s historical carrying value of the equity interests transferred as a transaction between entities under common control, totaling $174 million. We recognize equity earnings for Mattox prospectively from the date of acquisition, and record the distributions from Mattox as a reduction to the equity method investment balance.

We acquired an additional 25.97% interest in Explorer and an additional 10.125% interest in Colonial in the June 2019 Acquisition. As a result, these investments now qualify for equity method accounting as we have the ability to exercise significant influence over these investments as of the acquisition date. Prior to the acquisition date, Explorer and Colonial were accounted for as Other investments without readily determinable fair values and were therefore carried at cost. Upon acquisition, we added our Parent’s historical carrying value of the equity interests transferred as a transaction between entities under common control, totaling $90 million, to the basis of our previously held interests of $60 million as this is the date these investments qualified for equity method accounting. Since the June 2019 Acquisition, we record distributions from these investments as reductions to the respective equity method investment balances for Explorer and Colonial as these amounts are no longer considered dividend income due to the change in the method of accounting. We recognize equity earnings for both Explorer and Colonial prospectively from the date of acquisition.

For the years ended December 31, 2020, 2019 and 2018, distributions received from equity method investments were $541 million, $466 million and $301 million, respectively.

Unamortized differences in the basis of the initial investments and our interest in the separate net assets within the financial statements of the investees are amortized into net income over the remaining useful lives of the underlying assets. As of December 31, 2020 and 2019, the unamortized basis differences included in our equity method investments are $84 million and $92 million, respectively. For the years ended 2020, 2019 and 2018, the net amortization expense was $8 million, $6 million and $4 million, respectively, which is included in Income from equity method investments.

During the first quarter of 2018, the investment amount for Poseidon was reduced to zero due to distributions received that were in excess of our investment balance and we, therefore, suspended the equity method of accounting. As we have no commitments to provide further financial support to Poseidon, we have recorded excess distributions of $37 million, $33 million and $24 million in Other income for the years ended December 31, 2020, 2019 and 2018, respectively. Once our cumulative share of equity earnings becomes greater than the cumulative amount of distributions received, we will resume the equity method of accounting as long as the equity method investment balance remains greater than zero.
Earnings from our equity method investments were as follows during the periods indicated:

For the Year Ended December 31,
202020192018
Mattox (1)
$45 $— $— 
Amberjack (2)
102 125 80 
Mars114 126 108 
Bengal18 24 21 
Explorer (3)
44 41 — 
Colonial (3)
75 40 — 
Poseidon (4)
— — 
Other (5)
19 17 20 
$417 $373 $235 
(1) We acquired an interest in Mattox in the April 2020 Transaction. The acquisition of this interest has been accounted for prospectively.
(2) We acquired an interest in Amberjack in the May 2018 Acquisition. The acquisition of this interest has been accounted for prospectively.  
(3) We acquired additional interests in Explorer and Colonial in the June 2019 Acquisition. The acquisition of these interests has been accounted for prospectively.
(4) As stated above, the equity method of accounting has been suspended in 2018 for Poseidon and excess distributions are recorded in Other income.
(5) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.

The adoption of the revenue standard for the majority of our equity method investments followed the non-public business entity adoption date of January 1, 2019 for their stand-alone financial statements, with the exception of Mars and Permian Basin, which both adopted on January 1, 2018. As a result of adopting the revenue standard January 1, 2019 and 2018 by Amberjack and Mars, respectively, we recognized our proportionate share of each investment’s cumulative effect transition adjustment increasing the opening deficit in the amounts of $9 million and $7 million, respectively. The Amberjack adjustment is related to its dedication and transportation agreements, which contain tiered pricing arrangements resulting in a deferral of revenue. The Mars adjustment related to its transportation and dedication agreement and method of recognition as a stand-ready obligation, which resulted in a deferral of the recognition of revenue over the life of the contract, whereas under previous GAAP revenue was recognized upon physical delivery. The adoption of the revenue standard by our other equity method investments was not material.

Under the lease standard, the adoption date for our equity method investments will follow the non-public business entity adoption date of January 1, 2020 for their stand-alone financial statements, with the exception of Permian Basin, which adopted on January 1, 2019. There has been no material impact on the Partnership’s consolidated financial statements as a result of the adoption of the lease standard by our equity method investees.

On October 23, 2019, we entered into a Settlement Agreement with SPLC (the “Settlement Agreement”) with respect to the storage revenue reimbursement provision contained in the Purchase and Sale Agreement entered into in 2016 under which we acquired an additional 20% interest in Mars. As a result of the Settlement Agreement, we received approximately $9 million during the fourth quarter of 2019 from SPLC that was recognized as an additional capital contribution. Pursuant to the Purchase and Sale Agreement, SPLC agreed to pay us up to $10 million if Mars inventory management fees do not meet certain levels for the calendar years 2017 through 2021.

Based on our updated forecast and expectations of market conditions, we determined that there was a triggering event as of December 7, 2020 for our Permian Basin equity method investment that required us to update our impairment evaluation. The updated forecast had reductions in forecasted volumes gathered and processed by Permian Basin. Based on our evaluation, we determined that the fair value of our investment in Permian Basin was in excess of the carrying value as of December 7, 2020, and, therefore, there was no other-than-temporary impairment. However, if the facts and circumstances change in the near-term for Permian Basin and indicate a loss in value that is other-than-temporary, we will re-evaluate whether the carrying amount of this equity method investment may not be recoverable.

The fair value of the Permian Basin investment was determined based upon applying both the discounted cash flow method, which is an income approach, and a market approach. The discounted cash flow fair value estimate is based on known and knowable information at the measurement date. The significant assumptions that were used to develop the estimate of fair value
under the discounted cash flow method include management's best estimates of the expected future cash flows, including prices and volumes, the weighted average cost of capital and the long-term growth rate. Fair value determinations require considerable judgment and are sensitive to changes in underlying assumptions and factors. As a result, we cannot provide assurance that actual amounts will not vary significantly from estimated amounts.

Due to the continuing effects of the COVID-19 pandemic, we also evaluated whether an impairment indicator existed as of December 31, 2020 for our other equity method investments. Based on our current forecast and expectations of market conditions, we determined that there was no triggering event that required us to update our impairment evaluation of these equity method investments. However, if the facts and circumstances change in the near-term and indicate a loss in value that is other-than-temporary, we will re-evaluate whether the carrying amount of our equity method investments may not be recoverable.
Summarized Financial Information
The following tables present aggregated selected balance sheet and income statement data for our equity method investments on a 100% basis. However, during periods in which an acquisition occurs, the selected balance sheet and income statement data reflects activity from the date of the acquisition.
 
For the Year Ended December 31, 2020
Total revenuesTotal operating expensesOperating incomeNet income
Statements of Income
Mattox (1)
$66 $$57 $57 
Amberjack280 78 202 201 
Mars259 97 162 163 
Bengal65 30 35 35 
Explorer 329 175 154 119 
Colonial
1,395 660 735 473 
Poseidon147 36 111 105 
Other (2)
220 123 97 88 

As of December 31, 2020
Current assetsNon-current assetsTotal assetsCurrent liabilitiesNon-current liabilitiesEquity (deficit)Total liabilities and equity (deficit)
Balance Sheets
Mattox (1)
$13 $204 $217 $— $12 $205 $217 
Amberjack44 836 880 10 124 746 880 
Mars47 269 316 23 103 190 316 
Bengal33 161 194 — 187 194 
Explorer74 537 611 49 459 103 611 
Colonial501 3,105 3,606 245 3,508 (147)3,606 
Poseidon31 176 207 10 238 (41)207 
Other (2)
35 920 955 56 486 413 955 
(1) Our interest in Mattox was acquired in the April 2020 Transaction. Mattox’s total revenues, total operating expenses and operating income (on a 100% basis) were $85 million, $12 million and $73 million, respectively.
(2) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.
For the Year Ended December 31, 2019
Total revenuesTotal operating expensesOperating incomeNet income
Statements of Income
Amberjack
$315 $73 $242 $243 
Mars282 104 178 179 
Bengal77 30 47 47 
Explorer (1)
258 115 143 111 
Colonial (2)
829 449 380 255 
Poseidon132 35 97 87 
Other (3)
190 108 82 73 

As of December 31, 2019
Current assetsNon-current assetsTotal assetsCurrent liabilitiesNon-current liabilitiesEquity (deficit)Total liabilities and equity (deficit)
Balance Sheets
Amberjack$56 $804 $860 $$32 $824 $860 
Mars57 173 230 22 200 230 
Bengal35 157 192 — 186 192 
Explorer (1)
93 530 623 44 442 137 623 
Colonial (2)
323 2,920 3,243 519 2,873 (149)3,243 
Poseidon30 190 220 16 246 (42)220 
Other (3)
60 917 977 73 469 435 977 
(1) Our interest in Explorer was acquired on June 6, 2019. Explorer total revenues, total operating expenses and operating income (on a 100% basis) was $443 million, $196 million and $247 million, respectively.
(2) Our interest in Colonial was acquired on June 6, 2019. Colonial total revenues, total operating expenses and operating income (on a 100% basis) was $1,437 million, $735 million and $702 million, respectively.
(3) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.

For the Year Ended December 31, 2018
Total revenuesTotal operating expensesOperating incomeNet income
Statements of Income
Amberjack (1)
$204 $47 $157 $157 
Mars241 87 154 154 
Bengal69 28 41 41 
Poseidon116 35 81 73 
Other (2)
152 67 85 76 
As of December 31, 2018
Current assetsNon-current assetsTotal assetsCurrent liabilitiesNon-current liabilitiesEquity (deficit)Total liabilities and equity (deficit)
Balance Sheets
Amberjack (1)
$46 $846 $892 $$$884 $892 
Mars53 178 231 18 208 231 
Bengal27 156 183 — 174 183 
Poseidon19 203 222 16 243 (37)222 
Other (2)
50 876 926 65 456 405 926 
(1) Our interest in Amberjack was acquired on May 11, 2018. Amberjack total revenues, total operating expenses and operating income (on a 100% basis) was $295 million, $74 million and $221 million, respectively.
(2) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.
Capital Contributions
We make capital contributions for our pro rata interest in Permian Basin to fund capital and other expenditures. We made capital contributions to Permian Basin of zero, $25 million and $28 million in 2020, 2019 and 2018, respectively.